Page last updated: 2024-11-03

propranolol and Allergic Encephalomyelitis

propranolol has been researched along with Allergic Encephalomyelitis in 5 studies

Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.

Research Excerpts

ExcerptRelevanceReference
"Treatment with the beta-adrenergic agonist isoproterenol suppresses clinical and histological experimental allergic encephalomyelitis in Lewis rats."7.67The beta-adrenergic agonist isoproterenol suppresses experimental allergic encephalomyelitis in Lewis rats. ( Arnason, BG; Chelmicka-Schorr, E; Kwasniewski, MN; Thomas, BE, 1989)
"Treatment with the beta-adrenergic agonist isoproterenol suppresses clinical and histological experimental allergic encephalomyelitis in Lewis rats."3.67The beta-adrenergic agonist isoproterenol suppresses experimental allergic encephalomyelitis in Lewis rats. ( Arnason, BG; Chelmicka-Schorr, E; Kwasniewski, MN; Thomas, BE, 1989)
"Propranolol treatment over the effector phase moderated EAE course."1.56Propranolol diminished severity of rat EAE by enhancing immunoregulatory/protective properties of spinal cord microglia. ( Jasnić, N; Leposavić, G; Pilipović, I; Prijić, I; Stojić-Vukanić, Z, 2020)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's1 (20.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Pilipović, I4
Stojić-Vukanić, Z3
Leposavić, G4
Prijić, I1
Jasnić, N1
Vujnović, I1
Petrović, R1
Dimitrijević, M1
Rauski, A1
Radojević, K1
Kosec, D1
Stanojević, S1
Chelmicka-Schorr, E1
Kwasniewski, MN1
Thomas, BE1
Arnason, BG1

Reviews

1 review available for propranolol and Allergic Encephalomyelitis

ArticleYear
Adrenoceptors as potential target for add-on immunomodulatory therapy in multiple sclerosis.
    Pharmacology & therapeutics, 2023, Volume: 243

    Topics: Animals; Encephalomyelitis, Autoimmune, Experimental; Epstein-Barr Virus Infections; Female; Herpesv

2023

Other Studies

4 other studies available for propranolol and Allergic Encephalomyelitis

ArticleYear
Propranolol diminished severity of rat EAE by enhancing immunoregulatory/protective properties of spinal cord microglia.
    Neurobiology of disease, 2020, Volume: 134

    Topics: Adrenergic beta-Antagonists; Animals; CD4-Positive T-Lymphocytes; Cell Differentiation; Encephalomye

2020
Propranolol Impairs Primary Immune Responses in Rat Experimental Autoimmune Encephalomyelitis.
    Neuroimmunomodulation, 2019, Volume: 26, Issue:3

    Topics: Adrenergic beta-Antagonists; Animals; CD4-Positive T-Lymphocytes; Cell Movement; Encephalomyelitis,

2019
Beta-adrenoceptor blockade ameliorates the clinical course of experimental allergic encephalomyelitis and diminishes its aggravation in adrenalectomized rats.
    European journal of pharmacology, 2007, Dec-22, Volume: 577, Issue:1-3

    Topics: Adrenalectomy; Adrenergic beta-Antagonists; Animals; Brain; Corticosterone; Encephalomyelitis, Autoi

2007
The beta-adrenergic agonist isoproterenol suppresses experimental allergic encephalomyelitis in Lewis rats.
    Journal of neuroimmunology, 1989, Volume: 25, Issue:2-3

    Topics: Adrenergic beta-Agonists; Animals; Encephalomyelitis, Autoimmune, Experimental; Immunization; Isopro

1989